Research Antibodies Market Outlook:
Research Antibodies Market size was valued at USD 1.74 billion in 2025 and is likely to cross USD 2.81 billion by 2035, registering more than 4.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of research antibodies is assessed at USD 1.82 billion.
Research academia and industry collaboration has grown manifold in the past few years. This trend has helped the market growth of research antibodies flourish. In 2019, Absolute Antibody partnered with the University of Georgia for medical applications of research antibodies developed at the university. Such collaborative efforts boost the speed of research efforts and provide licensing rights of breakthrough research to key research antibodies market players which can be effectively applied in commercial applications. For instance, in January 2023, Ono Pharmaceuticals Co., Ltd entered a collaboration agreement with Monash University to develop antibodies for G Protein-coupled receptors (GPCRs). Through this, the company will obtain the worldwide rights to commercialize existing antibodies developed by Monash along with any new antibodies arising from research.
Research antibodies are essential detection tools to understand cell functions. Researchers can use antibodies to identify how a cell function has gone wrong during its life cycle. For instance, a National Library of Medicine report in 2023, stated monoclonal antibodies (mAbs) are rapidly entering clinical therapeutics and have shown promise against HIV and malaria. As research and development continue to develop, the commercial applications of antibodies will grow significantly.
